Experimental Cancer Drug Shows Promise
Company Will Seek Approval For Widespread Use
POSTED: 10:13 am EST August 11,
2004
UPDATED: 10:19 am EST August 11,
2004
An experimental cancer drug is showing promise in the treatment of head and neck tumors, RTV6 news reported.Advexin has been in development since the early 1990s by Introgen Therapeutics.The company will soon seek approval for its widespread use, officials said.
For more information on Advexin clinical trials, e-mail: clinicaltrials@introgen.com
|
|
Copyright 2004 by TheIndyChannel.com All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
